Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 4Phase EARLY_PHASE1 2Phase 3 2Phase 1 1

Status

Terminated 4Completed 3Withdrawn 2Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Glioma 1Diffuse Intrinsic Pontine Glioma 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 5pembrolizumab 4Biopsy 4durvalumab 3atezolizumab 3Radiotherapy 3Radiosurgery 3Cyclophosphamide 3Bevacizumab 3palbociclib 2niraparib 2abemaciclib 2Trastuzumab 2Temozolomide 2Taxes 2Surgical Procedures, Operative 2Specimen Handling 2Melphalan 2Letrozole 2Ketamine 2Irinotecan 2Hydrocortisone 2Gemcitabine 2Ferrosoferric Oxide 2Dexamethasone 2Curcumin 2Blood Specimen Collection 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × Blood Specimen Collection × Clear all
NCT04051047 2019-11-27

Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Withdrawn
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

NCT01302002 2016-02-23

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Instituto Nacional de Cancer, Brazil

Phase EARLY_PHASE1 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡